Robert W. Baird Cuts Cooper Companies (NASDAQ:COO) Price Target to $85.00

Cooper Companies (NASDAQ:COO) had its price objective cut by investment analysts at Robert W. Baird from $98.00 to $85.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has an “outperform” rating on the medical device company’s stock. Robert W. Baird’s price objective would indicate a potential upside of 37.05% from the stock’s previous close.

A number of other analysts also recently weighed in on COO. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Thursday. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a research note on Wednesday, March 4th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday. Finally, The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $83.86.

Cooper Companies Trading Up 2.8%

NASDAQ:COO opened at $62.02 on Friday. The firm has a market capitalization of $12.10 billion, a price-to-earnings ratio of 30.70, a PEG ratio of 1.56 and a beta of 0.87. The business’s 50-day moving average price is $65.17 and its two-hundred day moving average price is $74.57. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. Cooper Companies has a 1-year low of $58.89 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period last year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts expect that Cooper Companies will post 4.62 earnings per share for the current year.

Institutional Trading of Cooper Companies

Hedge funds have recently bought and sold shares of the stock. JANA Partners Management LP acquired a new stake in Cooper Companies during the 3rd quarter worth approximately $166,917,000. Alecta Tjanstepension Omsesidigt raised its stake in shares of Cooper Companies by 15.8% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after purchasing an additional 213,500 shares during the period. DAVENPORT & Co LLC raised its stake in shares of Cooper Companies by 1,359.7% in the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after purchasing an additional 528,346 shares during the period. Swiss Life Asset Management Ltd raised its stake in shares of Cooper Companies by 63.9% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after purchasing an additional 19,264 shares during the period. Finally, Fluent Financial LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at about $3,517,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.